227 related articles for article (PubMed ID: 38457199)
41. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
42. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
Chang ST; Lu YH; Lu CL; Weng SF; Lin SH; Kuo SY; Chuang YT; Takeuchi K; Ohshima K; Chuang SS
J Clin Pathol; 2014 Apr; 67(4):326-32. PubMed ID: 24218026
[TBL] [Abstract][Full Text] [Related]
43. Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population.
Hofscheier A; Ponciano A; Bonzheim I; Adam P; Lome-Maldonado C; Vela T; Cortes E; Ortiz-Hidalgo C; Fend F; Quintanilla-Martinez L
Mod Pathol; 2011 Aug; 24(8):1046-54. PubMed ID: 21499229
[TBL] [Abstract][Full Text] [Related]
44. Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.
Xie M; Huang X; Ye X; Qian W
Int Immunopharmacol; 2019 Dec; 77():105999. PubMed ID: 31704289
[TBL] [Abstract][Full Text] [Related]
45. Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma.
Shin DY; Kim A; Kang HJ; Park S; Kim DW; Lee SS
Cancer Lett; 2015 Aug; 364(2):89-97. PubMed ID: 25790907
[TBL] [Abstract][Full Text] [Related]
46. Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.
Ohashi A; Kato S; Okamoto A; Inaguma Y; Satou A; Tsuzuki T; Emi N; Okamoto M; Nakamura S
Histopathology; 2017 Jul; 71(1):89-97. PubMed ID: 28231401
[TBL] [Abstract][Full Text] [Related]
47. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
48. Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways.
Kato H; Karube K; Yamamoto K; Takizawa J; Tsuzuki S; Yatabe Y; Kanda T; Katayama M; Ozawa Y; Ishitsuka K; Okamoto M; Kinoshita T; Ohshima K; Nakamura S; Morishima Y; Seto M
Cancer Sci; 2014 May; 105(5):537-44. PubMed ID: 24581222
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma.
Kwon HJ; Yang JM; Lee JO; Lee JS; Paik JH
J Transl Med; 2018 Nov; 16(1):320. PubMed ID: 30458835
[TBL] [Abstract][Full Text] [Related]
50. EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features.
Ferreiro JF; Morscio J; Dierickx D; Vandenberghe P; Gheysens O; Verhoef G; Zamani M; Tousseyn T; Wlodarska I
Am J Transplant; 2016 Feb; 16(2):414-25. PubMed ID: 26780579
[TBL] [Abstract][Full Text] [Related]
51. PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro.
Quan L; Chen X; Liu A; Zhang Y; Guo X; Yan S; Liu Y
PLoS One; 2015; 10(9):e0136476. PubMed ID: 26361042
[TBL] [Abstract][Full Text] [Related]
52. Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing.
Gebauer N; Künstner A; Ketzer J; Witte HM; Rausch T; Benes V; Zimmermann J; Gebauer J; Merz H; Bernard V; Harder L; Ratjen K; Gesk S; Peter W; Busch Y; Trojok P; von Bubnoff N; Biersack H; Busch H; Feller AC
Blood Cancer J; 2021 May; 11(5):102. PubMed ID: 34039950
[TBL] [Abstract][Full Text] [Related]
53. Association of PD-1/PD-L1 expression and Epstein--Barr virus infection in patients with invasive breast cancer.
Zhang WT; Zhu GL; Xu WQ; Zhang W; Wang HZ; Wang YB; Li YX
Diagn Pathol; 2022 Jul; 17(1):61. PubMed ID: 35842661
[TBL] [Abstract][Full Text] [Related]
54. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a concise review and update.
Hong JY; Ko YH; Kim SJ; Kim WS
Curr Opin Oncol; 2015 Sep; 27(5):392-8. PubMed ID: 26258272
[TBL] [Abstract][Full Text] [Related]
55. The presence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on 'EBV-positive DLBCL of the elderly'.
Uner A; Akyurek N; Saglam A; Abdullazade S; Uzum N; Onder S; Barista I; Benekli M
APMIS; 2011 Apr; 119(4-5):309-16. PubMed ID: 21492232
[TBL] [Abstract][Full Text] [Related]
56. MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.
Ramis-Zaldivar JE; Gonzalez-Farre B; Nicolae A; Pack S; Clot G; Nadeu F; Mottok A; Horn H; Song JY; Fu K; Wright G; Gascoyne RD; Chan WC; Scott DW; Feldman AL; Valera A; Enjuanes A; Braziel RM; Smeland EB; Staudt LM; Rosenwald A; Rimsza LM; Ott G; Jaffe ES; Salaverria I; Campo E
Haematologica; 2021 Oct; 106(10):2682-2693. PubMed ID: 33951889
[TBL] [Abstract][Full Text] [Related]
57. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
58. [PD-L1 expression in EBV-associated gastric carcinomas].
Danilova NV; Sotnikova TN; Kalinin DV; Oleynikova NA; Chayka AV; Khomyakov VM; Kakotkin VV; Vychuzhanin DV; Andreeva YY; Malkov PG
Arkh Patol; 2022; 84(4):5-12. PubMed ID: 35880594
[TBL] [Abstract][Full Text] [Related]
59. Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland.
Ziarkiewicz M; Wołosz D; Dzieciątkowski T; Wilczek E; Dwilewicz-Trojaczek J; Jędrzejczak WW; Gierej B; Ziarkiewicz-Wróblewska B
Arch Immunol Ther Exp (Warsz); 2016 Apr; 64(2):159-69. PubMed ID: 26084760
[TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr Virus Promotes Tumorigenicity and Worsens Hodgkin Lymphoma Prognosis by Activating JAK/STAT and NF-κB Signaling Pathways.
Alabiad MA; Said WMM; Saad RHF; Balata R; Mahmoud AA; Metwally EA; Shalaby AM; Samy W; Yehia AM; Yahia AIO; Alorini M; Abdelrahman DI
Iran J Med Sci; 2024 Feb; 49(2):88-100. PubMed ID: 38356485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
